Welcome to LookChem.com Sign In|Join Free
  • or
N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE is a chemical compound with the molecular formula C11H12ClNO3. It is an amino acid derivative that has been studied for its potential pharmaceutical and biological properties. N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE is an acetylated derivative of beta-alanine, an amino acid that is a building block for carnosine and anserine. It also features a 2-chlorophenyl group, a compound commonly used in the production of pharmaceuticals and agrochemicals. The unique chemical structure and properties of N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE make it a promising candidate for various applications in the fields of medicine and pharmaceuticals.

886363-75-3

Post Buying Request

886363-75-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

886363-75-3 Usage

Uses

Used in Pharmaceutical Industry:
N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE is used as a pharmaceutical intermediate for the development of new drugs. Its unique structure and properties make it a valuable building block in the synthesis of various pharmaceutical compounds.
Used in Cardiovascular Disease Treatment:
N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE is used as a potential therapeutic agent for the treatment of cardiovascular diseases. Its biological properties and interactions with specific receptors or enzymes may contribute to the prevention or treatment of various cardiovascular conditions.
Used in Neurodegenerative Disorder Treatment:
N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE is used as a potential therapeutic agent for the treatment of neurodegenerative disorders. Its potential neuroprotective effects and ability to modulate specific signaling pathways may help in the management of diseases such as Alzheimer's, Parkinson's, and other related conditions.
Used in Drug Delivery Systems:
N-ACETYL-2-(2-CHLOROPHENYL)-DL-BETA-ALANINE is used as a component in drug delivery systems to improve the bioavailability and therapeutic efficacy of various drugs. Its unique chemical properties may allow for targeted delivery, controlled release, and enhanced stability of pharmaceutical compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 886363-75-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,6 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 886363-75:
(8*8)+(7*8)+(6*6)+(5*3)+(4*6)+(3*3)+(2*7)+(1*5)=223
223 % 10 = 3
So 886363-75-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H12ClNO3/c1-7(14)13-10(6-11(15)16)8-4-2-3-5-9(8)12/h2-5,10H,6H2,1H3,(H,13,14)(H,15,16)

886363-75-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-acetamido-3-(2-chlorophenyl)propanoic acid

1.2 Other means of identification

Product number -
Other names 3-Acetylamino-3-(2-chloro-phenyl)-propionicacid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:886363-75-3 SDS

886363-75-3Downstream Products

886363-75-3Relevant academic research and scientific papers

Carica papaya lipase catalysed resolution of β-amino esters for the highly enantioselective synthesis of (S)-dapoxetine

You, Pengyong,Qiu, Jian,Su, Erzheng,Wei, Dongzhi

, p. 557 - 565 (2013/03/13)

An efficient synthesis of the (S)-3-amino-3-phenylpropanoic acid enantiomer has been achieved by Carica papaya lipase (CPL) catalysed enantioselective alcoholysis of the corresponding racemic N-protected 2,2,2-trifluoroethyl esters in an organic solvent. A high enantioselectivity (E > 200) was achieved by two strategies that involved engineering of the substrates and optimization of the reaction conditions. Based on the resolution of a series of amino acids, it was found that the structure of the substrate has a profound effect on the CPL-catalysed resolution. The enantioselectivity and reaction rate were significantly enhanced by switching the conventional methyl ester to an activated trifluoroethyl ester. When considering steric effects, the substituted phenyl and amino groups should not both be large for the CPL-catalysed resolution. The mechanism of the CPL-catalysed enantioselective alcoholoysis of the amino acids is discussed to delineate the substrate requirements for CPL-catalysed resolution. Finally, the reaction was scaled up, and the products were separated and obtained in good yields (≥ 80 %). The (S)-3-amino-3- phenylpropanoic acid obtained was used as a key chiral intermediate in the synthesis of (S)-dapoxetine with very high enantiomeric excess (> 99 %). A carica papaya lipase catalysed resolution of N-protected β-phenylalanine esters has been developed. High enantioselectivity was achieved by two strategies that involved engineering of the substrates and optimization of the reaction conditions. After 50 % conversion, the products were separated and used as key chiral intermediates for the synthesis of (S)-dapoxetine with > 99 % ee. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 886363-75-3